|
C13ORF31 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.769500E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.95690000000171E-05 |
| Normal-vs-Stage2 |
6.916200E-01 |
| Normal-vs-Stage3 |
1.385700E-02 |
| Normal-vs-Stage4 |
4.399900E-02 |
| Stage1-vs-Stage2 |
1.335650E-03 |
| Stage1-vs-Stage3 |
3.084200E-01 |
| Stage1-vs-Stage4 |
5.777000E-01 |
| Stage2-vs-Stage3 |
3.178400E-02 |
| Stage2-vs-Stage4 |
5.622100E-02 |
| Stage3-vs-Stage4 |
8.570800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.231100E-04 |
| Normal-vs-AfricanAmerican |
1.177580E-02 |
| Normal-vs-Asian |
1.452080E-02 |
| Caucasian-vs-AfricanAmerican |
4.703600E-01 |
| Caucasian-vs-Asian |
7.935400E-01 |
| AfricanAmerican-vs-Asian |
6.532000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.251700E-02 |
| Normal-vs-Female |
2.398300E-04 |
| Male-vs-Female |
3.276000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.92498999999069E-05 |
| Normal-vs-Age(41-60Yrs) |
4.399700E-03 |
| Normal-vs-Age(61-80Yrs) |
4.095400E-01 |
| Normal-vs-Age(81-100Yrs) |
6.440400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.863800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.584700E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.127800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.242230E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.453600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.022000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.914800E-01 |
| Classical-VS-Follicular |
5.31209999987681E-07 |
| Classical-VS-Other |
4.510400E-01 |
| Classical-VS-Normal |
1.58269999994687E-06 |
| Tall-VS-Follicular |
3.656000E-03 |
| Tall-VS-Other |
4.281000E-01 |
| Tall-VS-Normal |
6.517700E-03 |
| Follicular-VS-Other |
3.741200E-01 |
| Follicular-VS-Normal |
5.386400E-01 |
| Other-VS-Normal |
3.266200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.633990E-01 |
| Normal-vs-N1 |
1.624280E-02 |
| N0-vs-N1 |
1.934950E-01 |
|
|
